Search Results - "YU, Jian Q"

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials by Weber, Wolfgang A, Gatsonis, Constantine A, Mozley, P David, Hanna, Lucy G, Shields, Anthony F, Aberle, Denise R, Govindan, Ramaswamy, Torigian, Drew A, Karp, Joel S, Yu, Jian Q Michael, Subramaniam, Rathan M, Halvorsen, Robert A, Siegel, Barry A

“…PET/CT with the glucose analog (18)F-FDG has several potential applications for monitoring tumor response to therapy in patients with non-small cell lung…”
Get full text

Multicenter Trial of [ 18 F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685 by Lowe, Val J, Duan, Fenghai, Subramaniam, Rathan M, Sicks, JoRean D, Romanoff, Justin, Bartel, Twyla, Yu, Jian Q Michael, Nussenbaum, Brian, Richmon, Jeremy, Arnold, Charles D, Cognetti, David, Stack, Jr, Brendan C

“…The objective of this study was to determine the negative predictive value (NPV) of positron emission tomography (PET)/computed tomography (CT) for the…”
Get full text

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing by Fernandez, Sandra V., Tan, Yin Fei, Rao, Shilpa, Fittipaldi, Patricia, Sheriff, Fathima, Borghaei, Hossein, Dotan, Efrat, Winn, Jennifer S., Edelman, Martin J., Treat, Joseph, Judd, Julia, Alpaugh, R. Katherine, Wang, Y. Lynn, Yu, Jian Q., Wasik, Mariusz, Baldwin, Don A.

“…A modified version of the PGDx elioTM Plasma Resolve assay was validated as a laboratory-developed test (LDT) for clinical use in the Molecular Diagnostics…”
Get full text

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy by Ali, Siraj M, Alpaugh, R Katherine, Downing, Sean R, Stephens, Philip J, Yu, Jian Q, Wu, Hong, Buell, Jamie K, Miller, Vincent A, Lipson, Doron, Palmer, Gary A, Ross, Jeffrey S, Cristofanilli, Massimo

Get full text

Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation by Konski, Andre, M.D., M.B.A., M.A, Li, Tianyu, M.S, Sigurdson, Elin, M.D, Cohen, Steven J., M.D, Small, William, M.D, Spies, Stewart, M.D, Yu, Jian Q., M.D, Wahl, Andrew, M.D, Stryker, Steven, M.D, Meropol, Neal J., M.D

“…Purpose To correlate changes in 2-deoxy-2-[18F]fluoro- d -glucose (18-FDG) positron emission tomography (PET) (18-FDG-PET) uptake with response and…”
Get full text

Renal Transplant Anastomotic Pseudoaneurysm and Stenosis at the Proximal Transplant Renal Artery and Worse Renal Blood Flow After Stent Placement by Wang, Jiaqiong, Li, Yi, Yu, Jian Q

“…A 60-year-old man with a history of end-stage renal disease received renal transplant and had decreasing renal function 4 months later. Nuclear medicine renal…”
Get full text

Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers by Doss, Mohan, Kolb, Hartmuth C, Walsh, Joseph C, Mocharla, Vani, Fan, Hong, Chaudhary, Ashok, Zhu, Zhihong, Alpaugh, R Katherine, Lango, Miriam N, Yu, Jian Q

“…(18)F-CP-18, or…”
Get full text

COVID-19 Vaccine–Related Local FDG Uptake by Doss, Mohan, Nakhoda, Shazia K., Li, Yi, Yu, Jian Q.

“…We present a case of increased FDG uptake in the lymph nodes after COVID-19 vaccine administration. Restaging PET/CT scan of a 70-year-old woman with a history…”
Get full text

Correlation of Molecular Response as Measured by 18-FDG Positron Emission Tomography With Outcome After Chemoradiotherapy in Patients with Esophageal Carcinoma by Konski, Andre A., M.D., M.B.A., M.A., F.A.C.R, Cheng, Jonathan D., M.D, Goldberg, Melvyn, M.D, Li, Tianyu, M.S, Maurer, Alan, M.D, Yu, Jian Q., M.D, Haluszka, Oleh, M.D, Scott, Walter, M.D, Meropol, Neal J., M.D, Cohen, Steven J., M.D, Freedman, Gary, M.D, Weiner, Louis M., M.D

“…Purpose To determine whether 18-fluorodeoxyglucose positron emission tomography (PET) computed tomography scans predict the pathologic complete response and…”
Get full text

Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using 18FDG-PET/CT by Shanmugan, Skandan, Arrangoiz, Rodrigo, Nitzkorski, James R., Yu, Jian Q., Li, Tianyu, Cooper, Harry, Konski, Andre, Farma, Jeffrey M., Sigurdson, Elin R.

“…Background Pathologic complete response (pCR) after neoadjuvant chemoradiation (CRT) has been observed in 15–30% of patients with locally advanced rectal…”
Get full text

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma by Leonard, John P., LaCasce, Ann S., Smith, Mitchell R., Noy, Ariela, Chirieac, Lucian R., Rodig, Scott J., Yu, Jian Q., Vallabhajosula, Shankar, Schoder, Heiko, English, Patricia, Neuberg, Donna S., Martin, Peter, Millenson, Michael M., Ely, Scott A., Courtney, Rachel, Shaik, Naveed, Wilner, Keith D., Randolph, Sophia, Van den Abbeele, Annick D., Chen-Kiang, Selina Y., Yap, Jeffrey T., Shapiro, Geoffrey I.

“…Mantle cell lymphoma (MCL) carries an unfavorable prognosis and requires new treatment strategies. The associated t(11:14) translocation results in enhanced…”
Get full text

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors by Gubbi, Sriram, Vijayvergia, Namrata, Yu, Jian Q, Klubo-Gwiezdzinska, Joanna, Koch, Christian A

“…Neuroendocrine tumors (NETs) occur in various regions of the body and present with complex clinical and biochemical phenotypes. The molecular underpinnings…”
Get more information

The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression by Fisher, Michael J., Basu, Sandip, Dombi, Eva, Yu, Jian Q., Widemann, Brigitte C., Pollock, Avrum N., Cnaan, Avital, Zhuang, Hongming, Phillips, Peter C., Alavi, Abass

“…Background The role of FDG–PET for managing patients with plexiform neurofibromas (PN) is unclear. While many PN tumors exhibit periods of rapid growth, others…”
Get full text

Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice by Schober, Jared P, Braun, Avery, Ginsburg, Kevin B, Bell, Spencer, Castro Bigalli, Alberto Andres, Chen, Michelle, Wang, Robert, Magee, Diana, Bukavina, Laura, Handorf, Elizabeth, Yu, Jian Q, Chen, David Y T, Greenberg, Richard E, Smaldone, Marc C, Viterbo, Rosalia, Correa, Andres F, Uzzo, Robert G, Kutikov, Alexander

“…Technetium-99m-sestamibi single-photon emission CT/x-ray CT is an emerging clinical tool to differentiate oncocytic tumors from renal cell carcinomas. We…”
Get full text

Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression by Lango, Miriam, Flieder, Douglas, Arrangoiz, Rodrigo, Veloski, Colleen, Yu, Jian Q, Li, Tianyu, Burtness, Barbara, Mehra, Ranee, Galloway, Tom, Ridge, John A

“…The impact of extranodal extension (ENE) of metastatic papillary thyroid carcinoma (PTC) on short- and long-term clinical outcomes, including biochemical…”
Get more information

Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer by Konski, Andre, Li, Tianyu, Christensen, Michael, Cheng, Jonathan D., Yu, Jian Q., Crawford, Kevin, Haluszka, Oleh, Tokar, Jeffrey, Scott, Walter, Meropol, Neal J., Cohen, Steven J., Maurer, Alan, Freedman, Gary M.

“…To determine factors associated with symptomatic cardiac toxicity in patients with esophageal cancer treated with chemoradiotherapy. We retrospectively…”
Get full text

The State-of-the-Art PET Tracers in Glioblastoma and High-grade Gliomas and Implications for Theranostics by Wang, Jiaqiong, Serafini, Aldo, Kuker, Russ, Ayubcha, Cyrus, Cohen, Gary, Nadel, Helen, McKinney, Alexander, Alavi, Abass, Yu, Jian Q.

“…MR imaging is currently the main imaging modality used for the diagnosis and post therapeutic assessment of glioblastomas. Recently, several innovative PET…”
Get full text

ACR–ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer by Savir-Baruch, Bital, Banks, Kevin P, McConathy, Jonathan E, Molchanova-Cook, Olga P, Parent, Ephraim E, Takalkar, Amol, Tulchinsky, Mark, Yu, Jian Q, Subramaniam, Rathan M, Schuster, David M

“…ABSTRACTThe American College of Radiology (ACR) and American College of Nuclear Medicine (ACNM) collaborated to develop a clinical practice document for the…”
Get full text

Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation by Sorenson, Eric, Lambreton, Fernando, Yu, Jian Q., Li, Tianyu, Denlinger, Crystal S., Meyer, Joshua E., Sigurdson, Elin R., Farma, Jeffrey M.

“…A major challenge in identifying candidates for nonoperative management of locally advanced rectal cancer is predicting pathologic complete response (pCR)…”
Get full text

Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma by Arrangoiz, Rodrigo, Papavasiliou, Pavlos, Stransky, Carrie A., Yu, Jian Q., Tianyu, Li, Sigurdson, Elin R., Berger, Adam C., Farma, Jeffrey M.

“…The yield of preoperative PET/CT (PET/CT) for regional and distant metastases for thin/intermediate thickness melanoma is low. Objective of this study is to…”
Get full text